Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384339407> ?p ?o ?g. }
- W4384339407 abstract "More than half of patients with high‑risk neuroblastoma (HR‑NB) experience relapse/regrowth due to the activation of chemoresistant minimal residual disease (MRD). MRD in patients with HR‑NB can be evaluated by quantitating neuroblastoma‑associated mRNAs (NB‑mRNAs) in bone marrow (BM) and peripheral blood (PB) samples. Although several sets of NB‑mRNAs have been shown to possess a prognostic value for MRD in BM samples (BM‑MRD), MRD in PB samples (PB‑MRD) is considered to be low and difficult to evaluate. The present report describes an HR‑NB case presenting higher PB‑MRD than BM‑MRD before 1st and 2nd relapse/regrowth. A 3‑year‑old female presented with an abdominal mass, was diagnosed with HR‑NB, and treated according to the nationwide standard protocol for HR‑NB. Following systemic induction and consolidation therapy with local therapy, the patient achieved complete remission but experienced a 1st relapse/regrowth 6 months after maintenance therapy. The patient partially responded to salvage chemotherapy and anti‑GD2 immunotherapy but had a 2nd relapse/regrowth 14 months after the 1st relapse/regrowth. Consecutive PB‑MRD and BM‑MRD monitoring revealed that PB‑MRD was lower than BM‑MRD at diagnosis (100 times) and 1st and 2nd relapse/regrowth (1,000 and 3 times) but became higher than BM‑MRD before 1st and 2nd relapse/regrowth. The present case highlights that PB‑MRD can become higher than BM‑MRD before relapse/regrowth of patients with HR‑NB." @default.
- W4384339407 created "2023-07-15" @default.
- W4384339407 creator A5005109435 @default.
- W4384339407 creator A5007720060 @default.
- W4384339407 creator A5010748774 @default.
- W4384339407 creator A5016189486 @default.
- W4384339407 creator A5018376228 @default.
- W4384339407 creator A5019701680 @default.
- W4384339407 creator A5025014885 @default.
- W4384339407 creator A5036092515 @default.
- W4384339407 creator A5042915753 @default.
- W4384339407 creator A5057002613 @default.
- W4384339407 creator A5072478939 @default.
- W4384339407 creator A5075571066 @default.
- W4384339407 creator A5076043257 @default.
- W4384339407 creator A5081794432 @default.
- W4384339407 creator A5084592358 @default.
- W4384339407 creator A5088368162 @default.
- W4384339407 creator A5089504357 @default.
- W4384339407 date "2023-07-14" @default.
- W4384339407 modified "2023-09-27" @default.
- W4384339407 title "Higher levels of minimal residual disease in peripheral blood than bone marrow before 1st and 2nd relapse/regrowth in a patient with high‑risk neuroblastoma: A case report" @default.
- W4384339407 cites W1824650450 @default.
- W4384339407 cites W1956957175 @default.
- W4384339407 cites W1966782038 @default.
- W4384339407 cites W2027657181 @default.
- W4384339407 cites W2057738343 @default.
- W4384339407 cites W2067606868 @default.
- W4384339407 cites W2099066165 @default.
- W4384339407 cites W2106514210 @default.
- W4384339407 cites W2131731825 @default.
- W4384339407 cites W2134597577 @default.
- W4384339407 cites W2141250302 @default.
- W4384339407 cites W2144575455 @default.
- W4384339407 cites W2145003578 @default.
- W4384339407 cites W2147575945 @default.
- W4384339407 cites W2152420890 @default.
- W4384339407 cites W2168420558 @default.
- W4384339407 cites W2183367751 @default.
- W4384339407 cites W2280912529 @default.
- W4384339407 cites W2343384129 @default.
- W4384339407 cites W2611071372 @default.
- W4384339407 cites W2619336038 @default.
- W4384339407 cites W2793376960 @default.
- W4384339407 cites W2948260295 @default.
- W4384339407 cites W2996601490 @default.
- W4384339407 cites W3163033016 @default.
- W4384339407 cites W4211031423 @default.
- W4384339407 doi "https://doi.org/10.3892/ol.2023.13955" @default.
- W4384339407 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37559575" @default.
- W4384339407 hasPublicationYear "2023" @default.
- W4384339407 type Work @default.
- W4384339407 citedByCount "0" @default.
- W4384339407 crossrefType "journal-article" @default.
- W4384339407 hasAuthorship W4384339407A5005109435 @default.
- W4384339407 hasAuthorship W4384339407A5007720060 @default.
- W4384339407 hasAuthorship W4384339407A5010748774 @default.
- W4384339407 hasAuthorship W4384339407A5016189486 @default.
- W4384339407 hasAuthorship W4384339407A5018376228 @default.
- W4384339407 hasAuthorship W4384339407A5019701680 @default.
- W4384339407 hasAuthorship W4384339407A5025014885 @default.
- W4384339407 hasAuthorship W4384339407A5036092515 @default.
- W4384339407 hasAuthorship W4384339407A5042915753 @default.
- W4384339407 hasAuthorship W4384339407A5057002613 @default.
- W4384339407 hasAuthorship W4384339407A5072478939 @default.
- W4384339407 hasAuthorship W4384339407A5075571066 @default.
- W4384339407 hasAuthorship W4384339407A5076043257 @default.
- W4384339407 hasAuthorship W4384339407A5081794432 @default.
- W4384339407 hasAuthorship W4384339407A5084592358 @default.
- W4384339407 hasAuthorship W4384339407A5088368162 @default.
- W4384339407 hasAuthorship W4384339407A5089504357 @default.
- W4384339407 hasBestOaLocation W43843394071 @default.
- W4384339407 hasConcept C126322002 @default.
- W4384339407 hasConcept C143998085 @default.
- W4384339407 hasConcept C2776694085 @default.
- W4384339407 hasConcept C2776715637 @default.
- W4384339407 hasConcept C2779823535 @default.
- W4384339407 hasConcept C2780007613 @default.
- W4384339407 hasConcept C54355233 @default.
- W4384339407 hasConcept C71924100 @default.
- W4384339407 hasConcept C81885089 @default.
- W4384339407 hasConcept C86803240 @default.
- W4384339407 hasConcept C90924648 @default.
- W4384339407 hasConceptScore W4384339407C126322002 @default.
- W4384339407 hasConceptScore W4384339407C143998085 @default.
- W4384339407 hasConceptScore W4384339407C2776694085 @default.
- W4384339407 hasConceptScore W4384339407C2776715637 @default.
- W4384339407 hasConceptScore W4384339407C2779823535 @default.
- W4384339407 hasConceptScore W4384339407C2780007613 @default.
- W4384339407 hasConceptScore W4384339407C54355233 @default.
- W4384339407 hasConceptScore W4384339407C71924100 @default.
- W4384339407 hasConceptScore W4384339407C81885089 @default.
- W4384339407 hasConceptScore W4384339407C86803240 @default.
- W4384339407 hasConceptScore W4384339407C90924648 @default.
- W4384339407 hasIssue "3" @default.
- W4384339407 hasLocation W43843394071 @default.
- W4384339407 hasLocation W43843394072 @default.
- W4384339407 hasLocation W43843394073 @default.
- W4384339407 hasOpenAccess W4384339407 @default.
- W4384339407 hasPrimaryLocation W43843394071 @default.